Pinnacle Financial Partners, Inc. filed an 8-K on September 10, 2026, disclosing that it amended and restated a letter agreement with Harold R. Carpenter on September 9, 2026, extending his non-compete and cooperation obligations through March 31, 2027 and modifying associated payments.
Fortrea Holdings Inc. filed a Form 8-K on September 10, 2026, reporting that its Board of Directors reinstated Jason Knoblauch as Chief Financial Officer and principal financial officer, effective September 9, 2026, following the resolution of a legal dispute with his prior employer.
Mobileye Global Inc. filed a Form 8-K on September 10, 2026, disclosing that its Board of Directors designated Chief Operating Officer Yaacov "Kobi" Ohayon as the company's principal operating officer and as a Section 16 executive officer, effective September 3, 2026.
Mobileye Global Inc. filed an 8-K on September 10, 2026, disclosing that Executive Vice President of Business Development and Strategy Nimrod Nehushtan transitioned to a part-time role focused on corporate strategy, effective September 3, 2026.
Tecnoglass Holdings Inc. filed a Form 8-K on September 10, 2026, announcing the timing for payment of its third-quarter 2026 quarterly cash dividend of $0.15 per share.
DuPont de Nemours, Inc. filed a Form 8-K on September 10, 2026, disclosing that it, along with The Chemours Company and Corteva Inc., entered into a settlement agreement on September 9, 2026, with the State of North Carolina and multiple state subdivisions to resolve …
Redwood Trust, Inc. filed a Form 8-K on September 10, 2026, disclosing third quarter 2026 common and preferred stock dividends declared by its Board of Directors, preliminary agreements to dispose of legacy bridge loans with an aggregate unpaid principal balance of up to approximately …
Village Farms International, Inc. filed an 8-K with the SEC on September 10, 2026, disclosing the appointment of Hamid Shekarchi as Interim Chief Financial Officer and the concurrent role transition of Stephen Ruffini, both effective September 10, 2026.
DiamondRock Hospitality Company, a Maryland-based hotel real estate investment trust listed on NASDAQ:DRH, filed a Form 8-K on September 10, 2026 disclosing that it intends to use a slide presentation at upcoming investor meetings, furnished under Regulation FD.
Prelude Therapeutics Incorporated filed a current report on Form 8-K on September 10, 2026, disclosing that the U.S. Food and Drug Administration cleared the company to proceed with a Phase 1 study for PRT13722, a KAT6A degrader being developed for HR+ breast cancer.